A multidisciplinary team of clinicians, engineers, and neuroscientists has identified a unique biomarker in the brain that indicates recovery from treatment-resistant depression, utilizing deep brain stimulation (DBS) and artificial intelligence. The discovery, which allows for real-time monitoring and tailoring of treatment, could revolutionize the approach to managing severe forms of depression.
New analysis sheds light on cancer incidence and mortality trends in the UK
Trends in cancer incidence and deaths in the United Kingdom (UK) among individuals aged between 35 and 69 years.
March 14, 2024